Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 21, 2022
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
[ Wed, Sep 21st 2022
] - WOPRAI
Tue, September 20, 2022
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
Dane Leone Maintained (BLUE) at Buy with Increased Target to $10 on, Sep 20th, 2022
Dane Leone of Raymond James, Maintained "bluebird bio, Inc." (BLUE) at Buy with Increased Target from $8 to $10 on, Sep 20th, 2022.
Dane has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Dane's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Thursday, August 18th, 2022
- Gena Wang of "Barclays" Upgraded from Sell to Hold and Increased Target to $5 on, Friday, August 5th, 2022
This is the rating of the analyst that currently disagrees with Dane
- Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $3 on, Friday, August 19th, 2022
